Advertisement
Screener

OptimizeRx Corporation (OPRX) Increase (Decrease) in Deferred Charges

2.8 / 5 stars · 68/120 Roast Me

OptimizeRx Corporation Increase (Decrease) in Deferred Charges

OptimizeRx Corporation (OPRX) reported Increase (Decrease) in Deferred Charges of $7.70 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-15.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2024-04-15

  • OptimizeRx Corporation increase (decrease) in deferred charges for fiscal 2023 was $7.70M.
Period endIncrease (Decrease) in Deferred Charges 12 month
2023-12-31$7.70M
10-K · filed 2024-04-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
TEN Holdings, Inc. (XHLD)United States$0.152B
Future FinTech Group Inc. (FTFT)$0.144B
Datavault AI Inc. (DVLT)United States$0.144B-1.77
RESOURCES CONNECTION, INC. (RGP)United States$0.129B-3.84
DHI GROUP, INC. (DHX)United States$0.205B132.15
COMSCORE, INC. (SCOR)United States$0.073B-6.35
Research Solutions, Inc. (RSSS)United States$0.071B27.67
Getty Images Holdings, Inc. (GETY)United States$0.068B-2.33
FiscalNote Holdings, Inc. (NOTE)United States$0.065B
Bridger Aerospace Group Holdings, Inc. (BAER)United States$0.049B-9.14